مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

251
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

82
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PRESENTATION OF A NOVEL MODEL FOR EVALUATION OF COMMERCIALIZATION OF RESEARCH AND DEVELOPMENT: CASE STUDY OF THE PHARMACEUTICAL BIOTECHNOLOGY INDUSTRY

Pages

  1214-1222

Abstract

 The current situation in Iran suggests an appropriate basis for developing biotechnologyindustries, because the patents for the majority of hi-tech medicines registered in developedcountries are ending. Biosimilar and technology-oriented companies which do not have patentswill have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present research proposed a model by which one can evaluate commercialization ofachievements obtained from research with a focus on the pharmaceutical biotechnologyindustry. This is a descriptive-analytic study where mixed methodology is followed by aheuristic approach. The statistical population was pharmaceutical biotechnology experts atuniversities and research centers in Iran. Structural equations were employed in this research. The results indicate that there are three effective layers within commercialization in theproposed model. These are a general layer (factors associated with management, human capital, legal infrastructure, communication infrastructure, a technical and executive infrastructures, and financial factors), industrial layer (internal industrial factors and pharmaceutical industryfactors), and a third layer that included national and international aspects. These layers comprise6 domains, 21 indices, 41 dimensions, and 126 components. Compilation of these layers (general layer, industrial layer, and national and internationalaspects) can serve commercialization of research and development as an effective EVALUATIONpackage.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    EMAMI, HASSAN, & RADFAR, REZA. (2017). PRESENTATION OF A NOVEL MODEL FOR EVALUATION OF COMMERCIALIZATION OF RESEARCH AND DEVELOPMENT: CASE STUDY OF THE PHARMACEUTICAL BIOTECHNOLOGY INDUSTRY. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 16(3), 1214-1222. SID. https://sid.ir/paper/288975/en

    Vancouver: Copy

    EMAMI HASSAN, RADFAR REZA. PRESENTATION OF A NOVEL MODEL FOR EVALUATION OF COMMERCIALIZATION OF RESEARCH AND DEVELOPMENT: CASE STUDY OF THE PHARMACEUTICAL BIOTECHNOLOGY INDUSTRY. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2017;16(3):1214-1222. Available from: https://sid.ir/paper/288975/en

    IEEE: Copy

    HASSAN EMAMI, and REZA RADFAR, “PRESENTATION OF A NOVEL MODEL FOR EVALUATION OF COMMERCIALIZATION OF RESEARCH AND DEVELOPMENT: CASE STUDY OF THE PHARMACEUTICAL BIOTECHNOLOGY INDUSTRY,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 16, no. 3, pp. 1214–1222, 2017, [Online]. Available: https://sid.ir/paper/288975/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button